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ABSTRACT
Objective: To evaluate whether occlusive salpingitis isth-
mica nodosa associated with endometriosis can be diag-
nosed by microlaparoscopy and managed with medical
therapy using leuprolide acetate.
Methods: This was a prospective, nonrandomized study
conducted at a university hospital and a private commu-
nity hospital. It included women with occlusive salpingitis
isthmica nodosa associated with endometriosis. Diagnosis
of salpingitis isthmica nodosa was made via microlaparos-
copy with chromotubation. Patients with occlusive salpin-
gitis isthmica nodosa were treated with leuprolide acetate
3.75 mg administered monthly for 6 months.
Results: Tubal patency in occlusive salpingitis isthmica
nodosa following medical therapy with leuprolide acetate
was evaluated. Thirteen of 16 (81.3%) women with bilat-
eral salpingitis isthmica nodosa achieved patency of both
fallopian tubes following treatment with leuprolide ace-
tate; 3 of 16 (18.8%) developed patency in one of the
fallopian tubes. All 5 women with unilateral SIN demon-
strated bilateral patency following medical therapy.
Conclusion: Diagnosis of occlusive salpingitis isthmica
nodosa can be made by microlaparoscopy. These prelim-
inary results suggest that medical therapy with leuprolide
acetate may be the first-line treatment modality for women
with occlusive salpingitis isthmica nodosa associated with
endometriosis, possibly avoiding a more invasive surgical
procedure.
Key Words: Microlaparoscopy, Endometriosis, Salpingitis
isthmica nodosa, Infertility, GnRH agonist, Leuprolide ac-
etate.
INTRODUCTION
Salpingitis isthmica nodosa (SIN) is associated with infer-
tility and the occurrence of tubal pregnancy.1–5 Tubal
involvement with endometriosis has been observed in
approximately 28% of SIN.6 Moderate or large numbers of
endometrial-like stromal cells accompany the diverticula
in more than half of the patients.7 Intramucosal endome-
triosis has been found in 14.3% of excised tubal segments
from women with uterotubal junction obstruction.8 Simi-
lar to adenomyosis of the uterus, glands appear to stimu-
late muscular growth, with subsequent mural thicken-
ing.3,7,9 The diagnosis of SIN is usually made by
hysterosalpingography (HSG).
However, an isthmic nodule noted during laparoscopy is
characteristic of SIN.10 Recent refinements in surgical tech-
nique and instrumentation have focused attention on min-
imally invasive microlaparoscopic surgery.11–13 Since
Chiari14 first described SIN in 1887, a myriad of treatment
modalities have been described. Surgical management is
generally undertaken when the condition is bilateral and
associated with infertility. More recently, tubocornual re-
section and anastomosis (TCA) by microsurgery for occlu-
sion due to SIN has been advocated.10 Some have sug-
gested bypassing microsurgery, and proceeding directly
to IVF.15
The objectives of this study were twofold: The first was to
perform a minimally invasive microlaparoscopic proce-
dure in women with chronic pelvic pain, and if endome-
triosis was found, to evaluate for the presence of occlusive
SIN. The second aim of this study was to measure the
efficacy of leuprolide acetate for achieving tubal patency
in patients with occlusive SIN associated with endometri-
osis.
METHODS
A prospective, nonrandomized study was performed be-
tween January 1998 and October 2003 with 87 consecu-
tive women who underwent microlaparoscopic evalua-
tion for chronic pelvic pain in the ambulatory surgery
center of a university-affiliated hospital and a private com-
munity hospital. All patients had a history of pelvic pain of
6-months’ duration or longer, and failed conservative
Department of Obstetrics and Gynecology, University of South Alabama College of
Medicine, Mobile, Alabama, USA (Dr Almeida).
Presented as a poster at the 13
th International Congress and Endo Expo 2004, SLS
Annual Meeting, New York, New York, September 29-October 2, 2004.
Address reprint requests to: Oscar D. Almeida, Jr., MD, 7009 Charleston
Oaks Dr South, Mobile, AL 36695 USA. Telephone: 251 605 2190, E-mail:
odalmeida@aol.com
© 2005 by JSLS, Journal of the Society of Laparoendoscopic Surgeons. Published by
the Society of Laparoendoscopic Surgeons, Inc.
JSLS (2005)9:431–433 431
SCIENTIFIC PAPERmedical therapy with oral contraceptives and nonsteroidal
anti- inflammatory (NSAIDS) medications. Twenty-one
women (median age 27.9 years, range 21 to 41; median
weight 147.5 lbs, range 100.9 to 229.1; median parity 0.43,
range 0 to 2) noted to have occlusive salpingitis isthmica
nodosa were included in the study. Occlusive SIN was
diagnosed under microlaparoscopic visualization when
an isthmic nodule with extravasation of methylene blue to
the serosa without spillage was noted (Figure 1). Women
diagnosed with SIN received medical therapy with leupro-
lide acetate 3.75 mg, administered intramuscularly at
monthly intervals for 6 months.
Following completion of medical therapy, all patients un-
derwent a hysterosalpingogram to evaluate for tubal pa-
tency.
RESULTS
All 21 women with occlusive SIN were included in the
analysis. Treatment with leuprolide acetate resulted in
increased tubal patency. Thirteen of 16 (81.3%) women
with bilateral SIN achieved bilateral tubal patency follow-
ing treatment with leuprolide acetate; 3 of 16 (18.8%)
achieved unilateral tubal patency. The 5 women with
unilateral SIN demonstrated bilateral tubal patency follow-
ing medical therapy. The mean number of unblocked
tubes as a result of medical therapy per patient was 1.62
(95% CI, range, 1.41 to 1.83). Staging of endometriosis
with associated SIN is summarized in Table 1.
DISCUSSION
Salpingitis isthmica nodosa is an acquired lesion analo-
gous to adenomyosis of the uterus. In the present study
population, 21 of the 87 women with endometriosis were
noted to have occlusive SIN (76% bilateral, 24% unilat-
eral). The incidence of SIN in the general population has
been reported to be between 0.6% and 11%.3,16 The inci-
dence of SIN in this study was 24.1%. The increased
incidence of SIN in this patient population is perhaps due
to the fact that all 87 women had endometriosis. Although
the diagnosis of SIN is readily made by hysterosalpingog-
raphy, laparoscopic observation of a proximal tubal nod-
ule is likewise characteristic. An evaluation of the pelvis
with microlaparoscopy through a 2-mm port affords an
excellent minimally invasive view of the pelvis, providing
additional information not available with a hysterosalpin-
gogram alone. Microlaparoscopy provides better cosmesis
than does traditional laparoscopy,17 while providing com-
parable efficacy for diagnosing endometriosis. Leuprolide
acetate is a long-acting GnRH analog that decreases se-
cretion of gonadal steroids. Tissues dependent on gonadal
steroids such as endometriosis become quiescent follow-
ing treatment with a GnRH analog. The women in this
study had an excellent response for achieving tubal pa-
tency following treatment with leuprolide acetate. Al-
though several pregnancies occurred following achieve-
ment of patency from occlusive SIN, some patients did not
desire pregnancy immediately and therefore pregnancies
were not included in the analysis. Until now, the most
common treatment modality for occlusive SIN has been
microsurgical resection of the lesion or canalization of the
tube. The results of this preliminary study suggest that
patients with occlusive SIN associated with endometriosis
may benefit from medical therapy using a GnRH analog to
achieve tubal patency, perhaps avoiding the more inva-
sive microsurgical resection and tubocornual anastomosis.
Figure 1. Uterine cornua seen at microlaparoscopy with salpin-
gitis isthmica nodosa nodule revealing serosal extravasation of
methylene blue.
Table 1.
Staging of Endometriosis With Associated
Salpingitis Isthmica Nodosa (SIN)
Stage Number of Patients SIN Unilateral Bilateral
I2 1 1
II 12 3 9
III 7 1 6
IV 0 0 0
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JSLS (2005)9:431–433 432Although the number of patients in this study is small, the
significant restoration of tubal patency noted following
medical therapy is encouraging.
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